ArticleBMJ open2019

Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol.

Yanhong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.